S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
TSE:CAS

Cascades (CAS) Stock Price, News & Analysis

C$9.29
+0.10 (+1.09%)
(As of 04/19/2024 ET)
Today's Range
C$9.15
C$9.37
50-Day Range
C$9.19
C$14.79
52-Week Range
C$9.14
C$15.00
Volume
108,166 shs
Average Volume
269,860 shs
Market Capitalization
C$935.60 million
P/E Ratio
N/A
Dividend Yield
5.17%
Price Target
C$11.60

Cascades MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
24.9% Upside
C$11.60 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.04mentions of Cascades in the last 14 days
Based on 21 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.51 out of 5 stars

CAS stock logo

About Cascades Stock (TSE:CAS)

Cascades Inc. produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards. It also engages in the recovery and recycling activities. Cascades Inc. was incorporated in 1964 and is headquartered in Kingsey Falls, Canada.

CAS Stock Price History

CAS Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Opening date set for North Cascades Highway
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Cascades (TSE:CAS) PT Lowered to C$12.00
Cascades (TSE:CAS) Price Target Cut to C$11.00
See More Headlines
Receive CAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cascades and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Dividend Payable
3/07/2024
Ex-Dividend for 3/7 Dividend
3/21/2024
Today
4/20/2024
Next Earnings (Confirmed)
5/09/2024

Industry, Sector and Symbol

Industry
Packaging & Containers
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$11.60
High Stock Price Target
C$13.00
Low Stock Price Target
C$11.00
Potential Upside/Downside
+24.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
C$-76,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$4.64 billion
Cash Flow
C$0.51 per share
Book Value
C$17.27 per share

Miscellaneous

Free Float
N/A
Market Cap
C$935.60 million
Optionable
Not Optionable
Beta
0.06
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Alain Lemaire Ph.D. (Age 77)
    Co-Founder & Executive Chairman
    Comp: $720.11k
  • Mr. Mario Plourde (Age 63)
    President, CEO & Non-Independent Director
    Comp: $2.54M
  • Mr. Allan Hogg CA
    VP & CFO
  • Mr. Luc Langevin
    Senior Vice President of Cascades Services
  • Mr. Charles Malo (Age 58)
    President & COO of Containerboard Packaging Group
    Comp: $1.07M
  • Mr. Dominic Doré
    Chief Supply Chain & Information Officer
  • Ms. Jennifer Aitken
    Director of Investor Relations
  • Mr. Robert F. Hall (Age 67)
    Chief of Strategy & Legal Affairs
    Comp: $1.22M
  • Mr. Hugo D'Amours
    Vice-President, Communications, Public Affairs & Sustainable Development
  • Mr. Riko Gaudreault ASA
    CFA, Vice President of Corporate Development

CAS Stock Analysis - Frequently Asked Questions

Should I buy or sell Cascades stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cascades in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CAS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAS, but not buy additional shares or sell existing shares.
View CAS analyst ratings
or view top-rated stocks.

What is Cascades' stock price target for 2024?

5 brokerages have issued twelve-month price targets for Cascades' shares. Their CAS share price targets range from C$11.00 to C$13.00. On average, they expect the company's stock price to reach C$11.60 in the next year. This suggests a possible upside of 24.9% from the stock's current price.
View analysts price targets for CAS
or view top-rated stocks among Wall Street analysts.

How have CAS shares performed in 2024?

Cascades' stock was trading at C$12.73 on January 1st, 2024. Since then, CAS shares have decreased by 27.0% and is now trading at C$9.29.
View the best growth stocks for 2024 here
.

When is Cascades' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our CAS earnings forecast
.

How were Cascades' earnings last quarter?

Cascades Inc. (TSE:CAS) posted its quarterly earnings results on Thursday, February, 22nd. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.30 by $0.25. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.22 billion. Cascades had a negative net margin of 1.64% and a negative trailing twelve-month return on equity of 2.86%.

How often does Cascades pay dividends? What is the dividend yield for Cascades?

Cascades announced a 1 dividend on Wednesday, March 6th. Shareholders of record on Thursday, March 21st will be given a dividend of 0.48 per share on Thursday, March 7th. This represents a dividend yield of 4.66%. The ex-dividend date of this dividend is Thursday, March 21st. This is an increase from the stock's previous 1 dividend of C$0.12.
Read our dividend analysis for CAS
.

Is Cascades a good dividend stock?

Cascades (TSE:CAS) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 5.02%. CAS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CAS.

What other stocks do shareholders of Cascades own?
How do I buy shares of Cascades?

Shares of CAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:CAS) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners